Occidental Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-35,386
Closed -$3.08M 212
2024
Q1
$3.08M Buy
35,386
+16,261
+85% +$1.39M 0.58% 49
2023
Q4
$1.58M Buy
19,125
+13,024
+213% +$993K 0.33% 83
2023
Q3
$478K Buy
+6,101
New +$511K 0.11% 135
2021
Q4
Sell
-1,678
Closed -$210K 212
2021
Q3
$210K Hold
1,678
0.05% 198
2021
Q2
$208K Buy
+1,678
New +$211K 0.06% 194
2017
Q3
Sell
-2,317
Closed -$206K 139
2017
Q2
$206K Buy
+2,317
New +$195K 0.12% 133
2016
Q4
Sell
-2,500
Closed -$216K 135
2016
Q3
$216K Sell
2,500
-100
-4% -$8.71K 0.18% 86
2016
Q2
$226K Buy
+2,600
New +$210K 0.2% 84

Other funds holding MDT

Occidental Asset Management's MDT Position: Q2 2024 in Review

Occidental Asset Management sold out of Medtronic (MDT) in Q2 2024, closing a stake of 35,386 shares — an estimated $3.08M sold.

Occidental Asset Management first reported a position in MDT in Q2 2016 and held it in 8 quarters. The position peaked at $3.08M in Q1 2024. 2,023 funds tracked by Wall St. Rank hold MDT as of Q2 2024.

  • Occidental Asset Management reported no remaining Medtronic position as of Q2 2024 after selling out during the quarter.
  • Occidental Asset Management sold 35,386 Medtronic shares in Q2 2024, an estimated $3.08M.
  • Occidental Asset Management first reported a position in Medtronic in Q2 2016 and held it in 8 quarters.
  • Occidental Asset Management's Medtronic position peaked at $3.08M in Q1 2024.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q2 2024.

Based on Occidental Asset Management's 13F filing for Q2 2024, filed 15 Jul 2024.